203 related articles for article (PubMed ID: 11775453)
1. EGF/ErbB receptor family in ovarian cancer.
Maihle NJ; Baron AT; Barrette BA; Boardman CH; Christensen TA; Cora EM; Faupel-Badger JM; Greenwood T; Juneja SC; Lafky JM; Lee H; Reiter JL; Podratz KC
Cancer Treat Res; 2002; 107():247-58. PubMed ID: 11775453
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer.
Lafky JM; Wilken JA; Baron AT; Maihle NJ
Biochim Biophys Acta; 2008 Apr; 1785(2):232-65. PubMed ID: 18291115
[TBL] [Abstract][Full Text] [Related]
3. mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells.
Gordon AW; Pegues JC; Johnson GR; Kannan B; Auersperg N; Stromberg K
Cancer Lett; 1995 Feb; 89(1):63-71. PubMed ID: 7882303
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases.
Stern DF
Breast Cancer Res; 2000; 2(3):176-83. PubMed ID: 11250707
[TBL] [Abstract][Full Text] [Related]
5. Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF.
Kurachi H; Morishige K; Adachi H; Adachi K; Tasaka K; Sawada M; Miyake A
Cancer; 1994 Dec; 74(11):2984-90. PubMed ID: 7954262
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of ErbB family receptor tyrosine kinases.
Sweeney C; Carraway KL
Br J Cancer; 2004 Jan; 90(2):289-93. PubMed ID: 14735165
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
8. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor.
Dong J; Opresko LK; Dempsey PJ; Lauffenburger DA; Coffey RJ; Wiley HS
Proc Natl Acad Sci U S A; 1999 May; 96(11):6235-40. PubMed ID: 10339571
[TBL] [Abstract][Full Text] [Related]
9. The epidermal growth factor/transforming growth factor-alpha family and their receptors.
Brown KD
Eur J Gastroenterol Hepatol; 1995 Oct; 7(10):914-22. PubMed ID: 8590134
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y
Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer.
Sheng Q; Liu J
Br J Cancer; 2011 Apr; 104(8):1241-5. PubMed ID: 21364581
[TBL] [Abstract][Full Text] [Related]
13. EGF-related peptides and their receptors in mammary gland development.
DiAugustine RP; Richards RG; Sebastian J
J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):109-17. PubMed ID: 10882297
[TBL] [Abstract][Full Text] [Related]
14. ErbB Receptors and Cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery.
Marzinke MA; Choi CH; Chen L; Shih IeM; Chan DW; Zhang H
Mol Cell Proteomics; 2013 Feb; 12(2):356-68. PubMed ID: 23172893
[TBL] [Abstract][Full Text] [Related]
16. ERbB-2 expression is rate-limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferation.
Hsieh SS; Malerczyk C; Aigner A; Czubayko F
Int J Cancer; 2000 Jun; 86(5):644-51. PubMed ID: 10797285
[TBL] [Abstract][Full Text] [Related]
17. Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants.
Junttila TT; Sundvall M; Määttä JA; Elenius K
Trends Cardiovasc Med; 2000 Oct; 10(7):304-10. PubMed ID: 11343971
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
[TBL] [Abstract][Full Text] [Related]
19. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor expression in human colon and colon carcinomas: anti-sense epidermal growth factor receptor RNA down-regulates the proliferation of human colon cancer cells.
Rajagopal S; Huang S; Moskal TL; Lee BN; el-Naggar AK; Chakrabarty S
Int J Cancer; 1995 Sep; 62(6):661-7. PubMed ID: 7558411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
